1
|
Watanabe M, Yakushijin K, Tanaka H, Chijiki R, Saeki M, Hirakawa Y, Takakura H, Usui Y, Ichikawa H, Sakai R, Matsumoto S, Nagao S, Mizutani Y, Kurata K, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Matsuoka H, Minami H. Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation. EJHAEM 2023; 4:192-198. [PMID: 36819160 PMCID: PMC9928647 DOI: 10.1002/jha2.586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Revised: 09/13/2022] [Accepted: 09/14/2022] [Indexed: 11/09/2022]
Abstract
Global longitudinal strain (GLS), a new cardiac parameter measured by the speckle-tracking method, is reportedly more sensitive than ejection fraction (EF) in detecting slight cardiac dysfunction in heart failure patients. We validated the utility of GLS in allogeneic hematopoietic stem cell transplantation (HSCT) patients during a long-term follow-up. Medical records of patients who underwent allogeneic HSCT between 2013 and 2020 were reviewed retrospectively. We evaluated the last echocardiography performed before transplantation and those performed annually during the 5 years after transplantation. We also investigated newly diagnosed cardiac events, which developed after HSCT. Among 85 patients, 22 used cardioprotective drugs. The median follow-up duration in surviving patients was 54.1 months (range, 2.9-92.6 months). GLS significantly decreased year by year, and patients taking cardioprotective agents tended to have a better GLS at 5 years than at 3 years, while EF did not change. Fifteen patients developed newly diagnosed cardiac events. Multivariate analysis revealed that low GLS and high serum ferritin levels at baseline were independently associated with the development of cardiac events. Therefore, we need a continuous follow-up of cardiac function by GLS and prescription of cardioprotective drugs might be considered for HSCT patients with low GLS. Further research is warranted.
Collapse
Affiliation(s)
- Marika Watanabe
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Kimikazu Yakushijin
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Hidekazu Tanaka
- Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan
| | - Ruri Chijiki
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Miki Saeki
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Yuri Hirakawa
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Hidetomo Takakura
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Yutaro Usui
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Hiroya Ichikawa
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Rina Sakai
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Sakuya Matsumoto
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Shigeki Nagao
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Yu Mizutani
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Keiji Kurata
- Jerome Lipper Multiple Myeloma Center Department of Medical Oncology Dana-Farber Cancer Institute Harvard Medical School Boston Massachusetts USA
| | - Akihito Kitao
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Yoshiharu Miyata
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
- BioResource Center Kobe University Hospital Kobe Japan
| | - Yasuyuki Saito
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Shinichiro Kawamoto
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Katsuya Yamamoto
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| | - Mitsuhiro Ito
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
- Laboratory of Hematology Division of Medical Biophysics Kobe University Graduate School of Health Sciences Kobe Japan
| | - Hiroshi Matsuoka
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
- BioResource Center Kobe University Hospital Kobe Japan
| | - Hironobu Minami
- Division of Medical Oncology and Hematology Department of Medicine Kobe University Hospital Kobe Japan
| |
Collapse
|
2
|
Deshmukh T, Emerson P, Geenty P, Mahendran S, Stefani L, Hogg M, Brown P, Panicker S, Chong J, Altman M, Gottlieb D, Thomas L. The utility of strain imaging in the cardiac surveillance of bone marrow transplant patients. Heart 2021; 108:550-557. [PMID: 34301770 DOI: 10.1136/heartjnl-2021-319359] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 06/14/2021] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVE To evaluate the utility of two-dimensional multiplanar speckle tracking strain to assess for cardiotoxicity post allogenic bone marrow transplantation (BMT) for haematological conditions. METHODS Cross-sectional study of 120 consecutive patients post-BMT (80 pretreated with anthracyclines (BMT+AC), 40 BMT alone) recruited from a late effects haematology clinic, compared with 80 healthy controls, as part of a long-term cardiotoxicity surveillance study (mean duration from BMT to transthoracic echocardiogram 6±6 years). Left ventricular global longitudinal strain (LV GLS), global circumferential strain (LV GCS) and right ventricular free wall strain (RV FWS) were compared with traditionl parameters of function including LV ejection fraction (LVEF) and RV fractional area change. RESULTS LV GLS (-17.7±3.0% vs -20.2±1.9%), LV GCS (-14.7±3.5% vs -20.4±2.1%) and RV FWS (-22.6±4.7% vs -28.0±3.8%) were all significantly (p=0.001) reduced in BMT+AC versus controls, while only LV GCS (-15.9±3.5% vs -20.4±2.1%) and RV FWS (-23.9±3.5% vs -28.0±3.8%) were significantly (p=0.001) reduced in BMT group versus controls. Even in patients with LVEF >53%, ~75% of patients in both BMT groups demonstrated a reduction in GCS. CONCLUSION Multiplanar strain identifies a greater number of BMT patients with subclinical LV dysfunction rather than by GLS alone, and should be evaluated as part of post-BMT patient surveillence. Reduction in GCS is possibly due to effects of preconditioning, and is not fully explained by AC exposure.
Collapse
Affiliation(s)
- Tejas Deshmukh
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.,Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
| | - Peter Emerson
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia
| | - Paul Geenty
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.,Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
| | | | - Luke Stefani
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.,Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
| | - Megan Hogg
- Haematology, Westmead Hospital, Sydney, New South Wales, Australia
| | - Paula Brown
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia
| | - Shyam Panicker
- Haematology, Westmead Hospital, Sydney, New South Wales, Australia
| | - James Chong
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.,Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.,Centre for Heart Research, Westmead Institute for Medical Research, Sydney, New South Wales, Australia
| | - Mikhail Altman
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia.,Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
| | - David Gottlieb
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.,Haematology, Westmead Hospital, Sydney, New South Wales, Australia
| | - Liza Thomas
- Cardiology, Westmead Hospital, Westmead, New South Wales, Australia .,Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.,South West Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia
| |
Collapse
|